Identification of a Case of CHARGE Syndrome
Abstract
CHARGE syndrome is a genetic disorder characterized by a specific and recognizable pattern of anomalies. It is estimated to occur in 1:10,000 births worldwide with various clinical manifestations. The major clinical features of CHARGE syndrome include ocular coloboma, heart malformations, atresia of the choanae, growth retardation, genital hypoplasia, and ear abnormalities. The underlying defect is in the chromodomain helicase DNA-binding protein 7 (CHD7) gene, which is located on chromosome 8q12.1. Around 67% of the patients clinically diagnosed with CHARGE syndrome have CHD7 mutations4 . So far, five hundred and twenty-eight unique alterations of CHD7 have been identified so far with no prefential domain being affected. The CHD7 gene encodes an adenosine triphosphate (ATP) dependent protein that participates in chromatin organization and plays a predominant role in neural tissue during fetal development. Majority of the CHD7 gene mutations occurs de novo. Familial transmission and germline mosaicism have rarely been identified.
Key Words:
CHARGE Syndrome, CHD7, Coloboma.
Additional Files
Published
Issue
Section
License
Copyright (c) 2024 Pakistan Journal of Medicine and Dentistry
This work is licensed under a Creative Commons Attribution 4.0 International License.
This is an open-access article distributed under the terms of the CreativeCommons Attribution License (CC BY) 4.0 https://creativecommons.org/licenses/by/4.0/